BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 950259)

  • 1. Analgesia, plasma levels, and dosage of propoxyphene.
    Waife SO; Gruber CM; Rodda BE; Nash JF
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):177-81. PubMed ID: 950259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problems and solutions to single-dose testing of analgesics: comparison of propoxyphene, codeine, and fenoprofen.
    Waife SO; Gruber CM; Rodda BE; Nash JF
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):301-4. PubMed ID: 1165140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of l-propoxyphene on plasma levels and analgesic activity of d-propoxyphene in the rat.
    Murphy PJ; Nickander RC; Bellamy GM; Kurtz WL
    J Pharmacol Exp Ther; 1976 Nov; 199(2):415-22. PubMed ID: 978493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-propoxyphene and dipyrone co-administration produces greater antinociception and fewer adverse effects than single treatments in rats.
    Silva-Moreno A; López-Muñoz FJ; Cruz SL
    Eur J Pharmacol; 2009 Apr; 607(1-3):84-90. PubMed ID: 19232342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous measurement of plasma levels of d-Propoxyphene and l-Propoxyphene using stable isotope labels and mass fragmentography.
    McMahon RE; Sullivan HR
    Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):631-41. PubMed ID: 959663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjustment of phenprocoumon dosage utilizing a pharmacokinetic model.
    Böhm K; Vogel G; Barthel W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):141-6. PubMed ID: 2459009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of propoxyphene in man. II. Pharmacokinetics.
    Wagner JG; Welling PG; Sedman AJ
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):381-8. PubMed ID: 5046052
    [No Abstract]   [Full Text] [Related]  

  • 8. Propoxyphene dependence and withdrawal.
    Strode SW
    Am Fam Physician; 1985 Sep; 32(3):105-8. PubMed ID: 4036770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-linear pharmacokinetics of aprindine hydrochloride in oral administration.
    Yokota M; Inagaki H; Uematsu H; Enomoto N; Goto J; Sotobata I; Takahashi A
    Arzneimittelforschung; 1987 Feb; 37(2):184-8. PubMed ID: 2437934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First human exposure to exogenous single-dose oral estetrol in early postmenopausal women.
    Visser M; Holinka CF; Coelingh Bennink HJ
    Climacteric; 2008; 11 Suppl 1():31-40. PubMed ID: 18464021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propoxyphene (dextropropoxyphene): a critical review of a weak opioid analgesic that should remain in antiquity.
    Barkin RL; Barkin SJ; Barkin DS
    Am J Ther; 2006; 13(6):534-42. PubMed ID: 17122535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open study of tolerability and pharmacokinetics of raclopride extended release capsules in psychiatric patients: a Canadian study.
    Gendron A; Sirois G; Nair NP; Bloom D; Movin-Osswald G; Uppfeldt G
    J Psychiatry Neurosci; 1995 Jul; 20(4):287-96. PubMed ID: 7647082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of first-pass effect on the systemic availability of propoxyphene.
    Perrier D; Gibaldi M
    J Clin Pharmacol New Drugs; 1972; 12(11):449-52. PubMed ID: 4484660
    [No Abstract]   [Full Text] [Related]  

  • 14. Dose response to fenoprofen in an antipyretic study of fenoprofen and propoxyphene.
    Gruber CM; Collins T
    J Med; 1977; 8(1):27-34. PubMed ID: 327002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis.
    Terziivanov D; Atanasova I; Dimitrova V; Robeva R; Unger S; Mück W
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. d-Propoxyphene kinetics after single oral and intravenous doses in man.
    Gram LF; Schou J; Way WL; Heltberg J; Bodin NO
    Clin Pharmacol Ther; 1979 Oct; 26(4):473-82. PubMed ID: 487695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of phenylbutazone in mature Holstein bulls: steady-state kinetics after multiple oral dosing.
    Williams RJ; Boudinot FD; Smith JA; Knight AP
    Am J Vet Res; 1990 Mar; 51(3):371-5. PubMed ID: 2316912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and relative potency assays with analgesic medications.
    Gruber CM
    J Med; 1983; 14(3):203-10. PubMed ID: 6580370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The concentration of propoxyphene in the plasma and analgesia scores in postpartum patients.
    Wolen RL; Gruber CM; Baptisti A; Scholz NE
    Toxicol Appl Pharmacol; 1971 Jul; 19(3):498-503. PubMed ID: 5106308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.